title: [Management of estrogen deficiency after breast cancer].
abstract: The prevention and the treatment of oestrogen deficiency induced by breast cancer treatments are crucial in the management of patients. The impacts of this deficiency must not be neglected: quality of life impairments inducing eventually premature withdrawal of hormonotherapies, and excess of bone and cardio-vascular morbidities and mortalities, especially in good prognosis young women. Management strategies of short and long term effects of this deficiency are reviewed and discussed here.
authors.affiliation: Service de Sénologie, CHU de Liège, Belgique.
authors.forename: J
authors.initials: J
authors.lastname: Desreux
authors.forename: V
authors.initials: V
authors.lastname: Bleret
authors.forename: A
authors.initials: A
authors.lastname: Pintiaux
authors.forename: A
authors.initials: A
authors.lastname: Béliard
authors.forename: F
authors.initials: F
authors.lastname: Kridelka
authors.forename: E
authors.initials: E
authors.lastname: Lifrange
authors.forename: J-R
authors.initials: JR
authors.lastname: Van Cauwenberge
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000628:therapy*; D004958:Estradiol / Q000172:deficiency*; D005260:Female; D006801:Humans; D008593:Menopause; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control; D011788:Quality of Life
chemical_list: D000970:Antineoplastic Agents; D004958:Estradiol